NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 237 filers reported holding NOVOCURE LTD in Q1 2024. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,143,443 | +6.3% | 125,128 | -3.0% | 0.04% | 0.0% |
| Q1 2024 | $2,015,676 | -23.9% | 128,962 | -27.3% | 0.04% | -2.3% |
| Q4 2023 | $2,648,597 | -62.0% | 177,401 | -58.9% | 0.04% | -67.9% |
| Q3 2023 | $6,975,395 | -41.1% | 431,913 | +51.5% | 0.13% | -42.7% |
| Q2 2023 | $11,834,804 | +136.5% | 285,176 | +242.8% | 0.23% | +131.7% |
| Q1 2023 | $5,003,708 | +2294.1% | 83,201 | +2660.5% | 0.10% | +1022.2% |
| Q2 2022 | $209,000 | -77.0% | 3,014 | -72.5% | 0.01% | -77.5% |
| Q1 2022 | $907,000 | -76.8% | 10,951 | -79.0% | 0.04% | -82.1% |
| Q4 2021 | $3,915,000 | +149.8% | 52,147 | +124.1% | 0.22% | -64.3% |
| Q1 2020 | $1,567,000 | +295.7% | 23,266 | +394.9% | 0.62% | +443.5% |
| Q4 2019 | $396,000 | – | 4,701 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |